Delivery Order SPE2DB22D1017-SPE2DB24FF8EH
Award Date 5/22/24
Potential Completion Date 5/23/24
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4564731036 RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $11,453.75 and an ultimate completion date of May 29, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,981.65 firm-fixed-price delivery order contract is for the supply of 4564885228 - RIFAMPIN 300 MG CAPSULE 60S. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.31 firm fixed-price delivery order contract is for the supply of RIFAMPIN 300 MG CAPSULE 30S, a critical pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,567,197,522 rifampin 300 mg capsules. The $4,802.64 firm-fixed-price delivery order contract has a completion date of February 10, 2025 and does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,228.34 firm fixed-price delivery order is for the supply of 4563080820 - RIFAMPIN 300 MG CAPSULE UD 100S, with a performance period through December 13, 2023. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, to the U.S. government. The contract, valued at $1,157.46, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 17, 2025. The contract is not set aside and was competitively...
- This federal contract award, valued at $14,375.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,222,276 units of RIFAMPIN 300 MG CAPSULE 30S, with a completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,996.76 delivery order contract is for the supply of Rifampin 300 mg capsules, a critical antibiotic medication. The contract has a firm fixed-price pricing type and an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE UD 100S, a pharmaceutical product, with a ceiling value of $13,155.36 and a performance period ending on July 11, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not set aside for any specific business type....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $5,415.76 firm fixed-price delivery order is for the supply of 300 mg Rifampin capsules. The contract has a completion date of June 10, 2024 and was awarded on June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...